Analyze Diet
Parasites & vectors2020; 13(1); 596; doi: 10.1186/s13071-020-04481-9

Equine seroprevalence of West Nile virus antibodies in the UK in 2019.

Abstract: West Nile virus (WNV) is a single-stranded RNA virus that can cause neurological disease in both humans and horses. Due to the movement of competent vectors and viraemic hosts, WNV has repeatedly emerged globally and more recently in western Europe. Within the UK, WNV is a notifiable disease in horses, and vaccines against the virus are commercially available. However, there has been no investigation into the seroprevalence of WNV in the UK equine population to determine the extent of vaccination or to provide evidence of recent infection. Methods: Equine serum samples were obtained from the Animal and Plant Health Agency's equine testing service between August and November 2019. A total of 988 serum samples were selected for horses resident in South East England. WNV seroprevalence was determined using two enzyme-linked immunosorbent assays (ELISAs) to detect total flavivirus antibodies and WNV-specific immunoglobulin M (IgM) antibodies. Positive IgM results were investigated by contacting the submitting veterinarian to establish the clinical history or evidence of prior vaccination of the horses in question. Results: Within the cohort, 274 samples tested positive for flavivirus antibodies, of which two subsequently tested positive for WNV-specific IgM antibodies. The follow-up investigation established that both horses had been vaccinated prior to serum samples being drawn, which resulted in an IgM-positive response. All the samples that tested positive by competition ELISA were from horses set to be exported to countries where WNV is endemic. Consequently, the positive results were likely due to previous vaccination. In contrast, 714 samples were seronegative, indicating that the majority of the UK equine population may be susceptible to WNV infection. Conclusions: There was no evidence for cryptic WNV infection in a cohort of horses sampled in England in 2019. All IgM-seropositive cases were due to vaccination; this should be noted for future epidemiological surveys in the event of a disease outbreak, as it is not possible to distinguish vaccinated from infected horses without knowledge of their clinical histories.
Publication Date: 2020-11-26 PubMed ID: 33243297PubMed Central: PMC7690108DOI: 10.1186/s13071-020-04481-9Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research examines the prevalence of West Nile virus (WNV) antibodies in the UK horse population, concluding that the cases with positive results were due to previous vaccination rather than infection and the majority of horses might be susceptible to the virus.

Research Methodology

  • The researchers gathered equine serum samples from the Animal and Plant Health Agency’s equine testing service, specifically selecting 988 samples from horses living in South East England. These samples were taken between August and November of 2019.
  • Two different enzyme-linked immunosorbent assays (ELISAs) were used to identify the presence of total flavivirus antibodies and West Nile virus-specific immunoglobulin M (IgM) antibodies.
  • If the samples tested positive for IgM antibodies, the research team investigated further by reaching out to the submitting veterinarian for encompassing information about the horse. This information included clinical history and records of prior vaccinations.

Results of the Research

  • A total of 274 samples indicated the presence of flavivirus antibodies. Among these, two samples had positive results for WNV-specific IgM antibodies.
  • Investigation revealed that both horses with IgM positivity had been vaccinated before the samples were taken.
  • Interestingly, all positive results through the competition ELISA were found in horses intended for export to countries with a high prevalence of WNV. The positive results were therefore likely resulting from previous vaccinations rather than infection with the virus.
  • The majority of the samples, 714 out of 988, were found to be seronegative, which interprets the possibility of a large portion of the UK equine population being vulnerable to WNV infection.

Conclusions and Implications

  • The study confirmed no evidence of cryptic (hidden or unnoticed) WNV infection in the sampled UK horses in 2019.
  • It was found that IgM-seropositive cases were entirely due to vaccination, not infection. This provides crucial insights for future epidemiological surveys, especially in the events of disease outbreaks.
  • It also emphasizes the importance of maintaining records of each horse’s vaccination and clinical history for accurate monitoring and disease prevention.
  • Given the majority of the horse population demonstrated a lack of WNV antibodies, the research underscores the potential vulnerability of horses in the UK to WNV infection, which requires continuous monitoring and preventive measures.

Cite This Article

APA
Folly AJ, Waller ESL, McCracken F, McElhinney LM, Roberts H, Johnson N. (2020). Equine seroprevalence of West Nile virus antibodies in the UK in 2019. Parasit Vectors, 13(1), 596. https://doi.org/10.1186/s13071-020-04481-9

Publication

ISSN: 1756-3305
NlmUniqueID: 101462774
Country: England
Language: English
Volume: 13
Issue: 1
Pages: 596
PII: 596

Researcher Affiliations

Folly, Arran J
  • Virology Department, Animal and Plant Health Agency, Woodham Lane, Surrey, UK. arran.folly@apha.gov.uk.
Waller, Elisabeth S L
  • Virology Department, Animal and Plant Health Agency, Woodham Lane, Surrey, UK.
McCracken, Fiona
  • Virology Department, Animal and Plant Health Agency, Woodham Lane, Surrey, UK.
McElhinney, Lorraine M
  • Virology Department, Animal and Plant Health Agency, Woodham Lane, Surrey, UK.
  • Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Roberts, Helen
  • Exotic Disease Control Team, Defra, 17 Smith Square, London, UK.
Johnson, Nicholas
  • Virology Department, Animal and Plant Health Agency, Woodham Lane, Surrey, UK.
  • Faculty of Health and Medicine, University of Surrey, Guildford, UK.

MeSH Terms

  • Animals
  • Antibodies, Viral / blood
  • Cohort Studies
  • Horse Diseases / blood
  • Horse Diseases / epidemiology
  • Horse Diseases / virology
  • Horses
  • Immunoglobulin G / blood
  • Seroepidemiologic Studies
  • United Kingdom
  • West Nile Fever / blood
  • West Nile Fever / epidemiology
  • West Nile Fever / veterinary
  • West Nile Fever / virology
  • West Nile virus / genetics
  • West Nile virus / immunology
  • West Nile virus / isolation & purification

Grant Funding

  • SE0555 / United Kingdom, Department for Environment, Food and Rural affairs

Conflict of Interest Statement

The authors declare that they have no competing interests.

References

This article includes 18 references
  1. Smithburn K, Hughes T, Burke A. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med Hyg 1940;20:471–492.
  2. Angenvoort J, Brault AC, Bowen RA, Groschup MH. West Nile viral infection of equids.. Vet Microbiol 2013 Nov 29;167(1-2):168-80.
  3. Ziegler U, Lühken R, Keller M, Cadar D, van der Grinten E, Michel F, Albrecht K, Eiden M, Rinder M, Lachmann L, Höper D, Vina-Rodriguez A, Gaede W, Pohl A, Schmidt-Chanasit J, Groschup MH. West Nile virus epizootic in Germany, 2018.. Antiviral Res 2019 Feb;162:39-43.
  4. Jiménez-Clavero MA, Llorente F, Sotelo E, Soriguer R, Gómez-Tejedor C, Figuerola J. West Nile virus serosurveillance in horses in Donana, Spain, 2005 to 2008.. Vet Rec 2010 Sep 4;167(10):379-80.
    doi: 10.1136/vr.c3155pubmed: 20817900google scholar: lookup
  5. Ziegler U, Angenvoort J, Klaus C, Nagel-Kohl U, Sauerwald C, Thalheim S, Horner S, Braun B, Kenklies S, Tyczka J, Keller M, Groschup MH. Use of competition ELISA for monitoring of West Nile virus infections in horses in Germany.. Int J Environ Res Public Health 2013 Jul 24;10(8):3112-20.
    pmc: PMC3774427pubmed: 23887620doi: 10.3390/ijerph10083112google scholar: lookup
  6. Benjelloun A, El Harrak M, Calistri P, Loutfi C, Kabbaj H, Conte A, Ippoliti C, Danzetta ML, Belkadi B. Seroprevalence of West Nile virus in horses in different Moroccan regions.. Vet Med Sci 2017 Nov;3(4):198-207.
    doi: 10.1002/vms3.71pmc: PMC5677775pubmed: 29152314google scholar: lookup
  7. Mansfield KL, Horton DL, Johnson N, Li L, Barrett ADT, Smith DJ, Galbraith SE, Solomon T, Fooks AR. Flavivirus-induced antibody cross-reactivity.. J Gen Virol 2011 Dec;92(Pt 12):2821-2829.
    doi: 10.1099/vir.0.031641-0pmc: PMC3352572pubmed: 21900425google scholar: lookup
  8. Lecollinet S, Pronost S, Coulpier M, Beck C, Gonzalez G, Leblond A, Tritz P. Viral Equine Encephalitis, a Growing Threat to the Horse Population in Europe?. Viruses 2019 Dec 24;12(1).
    doi: 10.3390/v12010023pmc: PMC7019608pubmed: 31878129google scholar: lookup
  9. Khatibzadeh SM, Gold CB, Keggan AE, Perkins GA, Glaser AL, Dubovi EJ, Wagner B. West Nile virus-specific immunoglobulin isotype responses in vaccinated and infected horses.. Am J Vet Res 2015 Jan;76(1):92-100.
    doi: 10.2460/ajvr.76.1.92pubmed: 25535666google scholar: lookup
  10. Parkash V, Woods K, Kafetzopoulou L, Osborne J, Aarons E, Cartwright K. West Nile Virus Infection in Travelers Returning to United Kingdom from South Africa.. Emerg Infect Dis 2019 Feb;25(2):367-369.
    doi: 10.3201/eid2502.172101pmc: PMC6346434pubmed: 30666938google scholar: lookup
  11. Blagrove MS, Sherlock K, Chapman GE, Impoinvil DE, McCall PJ, Medlock JM, Lycett G, Solomon T, Baylis M. Evaluation of the vector competence of a native UK mosquito Ochlerotatus detritus (Aedes detritus) for dengue, chikungunya and West Nile viruses.. Parasit Vectors 2016 Aug 15;9:452.
    doi: 10.1186/s13071-016-1739-3pmc: PMC4986171pubmed: 27527700google scholar: lookup
  12. Bessell PR, Robinson RA, Golding N, Searle KR, Handel IG, Boden LA, Purse BV, Bronsvoort BM. Quantifying the Risk of Introduction of West Nile Virus into Great Britain by Migrating Passerine Birds.. Transbound Emerg Dis 2016 Oct;63(5):e347-59.
    doi: 10.1111/tbed.12310pubmed: 25516263google scholar: lookup
  13. Szmaragd C, Wilson AJ, Carpenter S, Wood JL, Mellor PS, Gubbins S. The spread of bluetongue virus serotype 8 in Great Britain and its control by vaccination.. PLoS One 2010 Feb 22;5(2):e9353.
  14. Phipps LP, Duff JP, Holmes JP, Gough RE, McCracken F, McElhinney LM, Johnson N, Hughes L, Chantrey J, Pennycott T, Murray KO, Brown IH, Fooks AR. Surveillance for West Nile virus in British birds (2001 to 2006).. Vet Rec 2008 Mar 29;162(13):413-5.
    doi: 10.1136/vr.162.13.413pubmed: 18375986google scholar: lookup
  15. British Equestrian Trade Association. National Equestrian Survey 2019. Accessed 01 July 2020.
  16. Fooks AR, Horton DL, Phipps LP, Mansfield KL, McCracken F, Jeffries CL. Suspect West Nile virus encephalitis in a horse imported into the UK from Europe. Vet Rec Case Rep 2014;2:e000104.
  17. Holding M, Dowall SD, Medlock JM, Carter DP, Pullan ST, Lewis J, Vipond R, Rocchi MS, Baylis M, Hewson R. Tick-Borne Encephalitis Virus, United Kingdom.. Emerg Infect Dis 2020 Jan;26(1):90-96.
    doi: 10.3201/eid2601.191085pmc: PMC6924911pubmed: 31661056google scholar: lookup
  18. Beck C, Lowenski S, Durand B, Bahuon C, Zientara S, Lecollinet S. Improved reliability of serological tools for the diagnosis of West Nile fever in horses within Europe.. PLoS Negl Trop Dis 2017 Sep;11(9):e0005936.

Citations

This article has been cited 8 times.
  1. Gothe LMR, Ganzenberg S, Ziegler U, Obiegala A, Lohmann KL, Sieg M, Vahlenkamp TW, Groschup MH, Hörügel U, Pfeffer M. Horses as Sentinels for the Circulation of Flaviviruses in Eastern-Central Germany. Viruses 2023 Apr 30;15(5).
    doi: 10.3390/v15051108pubmed: 37243194google scholar: lookup
  2. Folly AJ, Sewgobind S, Hernández-Triana LM, Mansfield KL, Lean FZX, Lawson B, Seilern-Moy K, Cunningham AA, Spiro S, Wrigglesworth E, Pearce-Kelly P, Herdman T, Johnston C, Berrell M, Vaux AGC, Medlock JM, Johnson N. Evidence for overwintering and autochthonous transmission of Usutu virus to wild birds following its redetection in the United Kingdom. Transbound Emerg Dis 2022 Nov;69(6):3684-3692.
    doi: 10.1111/tbed.14738pubmed: 36217722google scholar: lookup
  3. Ganzenberg S, Sieg M, Ziegler U, Pfeffer M, Vahlenkamp TW, Hörügel U, Groschup MH, Lohmann KL. Seroprevalence and Risk Factors for Equine West Nile Virus Infections in Eastern Germany, 2020. Viruses 2022 May 30;14(6).
    doi: 10.3390/v14061191pubmed: 35746662google scholar: lookup
  4. Bergmann F, Trachsel DS, Stoeckle SD, Bernis Sierra J, Lübke S, Groschup MH, Gehlen H, Ziegler U. Seroepidemiological Survey of West Nile Virus Infections in Horses from Berlin/Brandenburg and North Rhine-Westphalia, Germany. Viruses 2022 Jan 25;14(2).
    doi: 10.3390/v14020243pubmed: 35215837google scholar: lookup
  5. Johnson N, Golding M, Phipps LP. Detection of Tick-Borne Pathogens in Red Deer (Cervus elaphus), United Kingdom. Pathogens 2021 May 23;10(6).
    doi: 10.3390/pathogens10060640pubmed: 34070977google scholar: lookup
  6. Hamouche C, Pradel J, Pagès N, Chevalier V, Lecollinet S, Bastard J, Durand B. Reconstructing the silent circulation of West Nile Virus in a Caribbean island during 15 years using sentinel serological data. PLoS Negl Trop Dis 2025 Jun;19(6):e0012895.
    doi: 10.1371/journal.pntd.0012895pubmed: 40549806google scholar: lookup
  7. Li L, Li S, Ma H, Akhtar MF, Tan Y, Wang T, Liu W, Khan A, Khan MZ, Wang C. An Overview of Infectious and Non-Infectious Causes of Pregnancy Losses in Equine. Animals (Basel) 2024 Jul 2;14(13).
    doi: 10.3390/ani14131961pubmed: 38998073google scholar: lookup
  8. Schilling M, Dunkel B, Floyd T, Hicks D, Nunez A, Steinbach F, Folly AJ, Johnson N. Fatal West Nile Virus Infection in Horse Returning to United Kingdom from Spain, 2022. Emerg Infect Dis 2024 Feb;30(2):396-398.
    doi: 10.3201/eid3002.230690pubmed: 38270166google scholar: lookup